ⓘ Lumretuzumab

                                     

ⓘ Lumretuzumab

Lumretuzumab is a humanized monoclonal antibody designed for the treatment of cancer.

This drug developed by Genentech / Roche.

                                     
  • Lumiliximab mab chimeric CD23 IgE receptor chronic lymphocytic leukemia Lumretuzumab mab humanized ERBB3 HER3 cancer Lupartumab mab human Lupartumab amadotin